Model Oncology
Bellaire, US · Founded 2024 · Delaware LLC
Find your way into Model Oncology
Sign up to see every warm intro you have to Model Oncology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Model Oncology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SC

TJ
THOMAS J. HARPERNamed on SEC filing
PH
PHILLIP H. WATTSNamed on SEC filing
TJ
THOMAS J. HARPER, JR.Named on SEC filing
WB
WILLIAM B. DOWNEYNamed on SEC filing
SM
STANLEY M. MARKS, MDNamed on SEC filing
MB
MAX BUETOWNamed on SEC filing
Board
RA
ROBERT A. ORTENZIOBoard director
DS
DAVID S. CHERNOWBoard director
MF
MARTIN F. JACKSONBoard director
Reported raises · per SEC filings
Form D private placements$25.9M disclosed across 2 rounds · 2024–2026
▶$10.9MraisedOct 2026 · 30 investors · Other Health CareRule 506(b)
▶$10.9MraisedOct 2026 · 30 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- THOMAS J. HARPER, JR.Executive Officer, Promoter
- DAVID S. CHERNOWExecutive Officer, Director
- ROBERT A. ORTENZIODirector
- MARTIN F. JACKSONDirector
- WILLIAM B. DOWNEYDirector
- STANLEY M. MARKS, MDDirector
- MAX BUETOWDirector
- PHILLIP H. WATTSPromoter
- STEVEN CUTLERPromoter
- Offering amount
- $17.5M
- Amount sold
- $10.9M
- Minimum investment
- $100K
- First sale
- Oct 2026
- Incorporated
- Limited Liability Company, Delaware, 2024
- Federal exemptions
- 06b
▶$15MraisedDec 2024 · 6 investors · Other Health CareRule 506(b)
▶$15MraisedDec 2024 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- THOMAS J. HARPERExecutive Officer, Promoter
- ROBERT A. ORTENZIODirector
- DAVID S. CHERNOWDirector
- MARTIN F. JACKSONDirector
- PHILLIP H. WATTSExecutive Officer, Director, Promoter
- STEVEN CUTLERExecutive Officer, Promoter
- Offering amount
- $15M
- Amount sold
- $15M
- Minimum investment
- $500K
- First sale
- Dec 2024
- Incorporated
- Limited Liability Company, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Model Oncology raised?
- Model Oncology has disclosed $25.9M raised across 2 rounds.
- Where is Model Oncology headquartered?
- Model Oncology is headquartered in Bellaire, US.